deuruxolitinib phosphate

FDA Drug Profile — LEQSELVI

Drug Details

Generic Name
deuruxolitinib phosphate
Brand Names
LEQSELVI
Application Number
NDA217900
Sponsor
Sun Pharmaceutical Industries, Inc.
NDC Codes
1
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
DEURUXOLITINIB PHOSPHATE

Indications and Usage

1 INDICATIONS AND USAGE LEQSELVI™ is indicated for the treatment of adult patients with severe alopecia areata. Limitations of Use LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants. LEQSELVI is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with severe alopecia areata. ( 1 ) Limitations of Use: LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants. ( 1 )